PRIMACOR

This brand name is authorized in Brazil, Hong Kong SAR China, Malta, Mexico, New Zealand, Singapore, UK.

Active ingredients

The drug PRIMACOR contains one active pharmaceutical ingredient (API):

1	Milrinone UNII 9K8XR81MO8 - MILRINONE LACTATE
	Milrinone is a positive inotrope and vasodilator, with little chronotropic activity. It also improves left ventricular diastolic relaxation. It is a selective inhibitor of peak III phosphodiesterase isoenzyme in cardiac and vascular muscle. It produces slight enhancement of A-V node conduction, but no other significant electrophysiological effects.
	Read more about Milrinone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PRIMACOR Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01CE02	Milrinone	C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CE Phosphodiesterase inhibitors
Discover more medicines within C01CE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576720070075717
GB	Medicines & Healthcare Products Regulatory Agency	46469
HK	Department of Health Drug Office	36347
MT	Medicines Authority	AA565/54501
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	255M99
NZ	Medicines and Medical Devices Safety Authority	5324
SG	Health Sciences Authority	07633P